Post date December 11, 2023 Experience Atour Lifestyle Holdings $174.4 million secondary offering We advised Atour on a secondary offering of ADSs
Post date December 8, 2023 Experience Innovent Biologics HK$2.4 billion placement of shares The shares are listed on the Hong Kong Stock Exchange
Post date December 7, 2023 Experience Weibo concurrent $330 million convertible notes and $63.5 million ADS offerings The company also entered into an ADS lending agreement in connection with the ADS offering
Post date December 4, 2023 Experience Tencent $100 million strategic investment in Global Blue Group Holding We advised Tencent on the transaction
Post date November 21, 2023 Experience WuXi XDC Cayman HK$3.68 billion IPO The shares are listed on the HKEX
Post date August 10, 2023 Experience Gracell Biotechnologies PIPE of ordinary shares and warrants The company’s ADSs are listed on Nasdaq
Post date June 29, 2023 Experience Laekna HK$791 million IPO We advised Laekna on its IPO and HKEX listing
Post date June 27, 2023 Experience Red Star Macalline Group consent solicitation We advised Red Star Macalline on the transaction
Post date June 20, 2023 Experience Tonglu New City Development Investment RMB804 million credit-enhanced bonds The credit-enhanced bonds are due 2026